Phase II Trial of Epirubicin Cisplatin and FU Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer.
Phase of Trial: Phase II
Latest Information Update: 27 Jun 2011
At a glance
- Drugs Endostatin (Primary) ; Cisplatin; Epirubicin; Fluorouracil
- Indications Gastric cancer
- Focus Therapeutic Use
- 27 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 31 Aug 2010 Planned end date changed from 1 Dec 2009 to 1 Dec 2010 as reported by ClinicalTrials.gov.
- 27 May 2009 New trial record